Project

From Omics to Patient: Improving Diagnostics of Pathogenic Yeasts

Acronym
OPATHY
Code
41J05615
Duration
01 September 2015 → 31 August 2019
Funding
European funding: framework programme
Research disciplines
  • Medical and health sciences
    • Laboratory medicine
    • Laboratory medicine
    • Laboratory medicine
Keywords
Pathogenic Yeasts
Other information
 
Project description

OPATHY (from Omics of PATHogenics Yeasts) is an innovative translational research training network that will

explore the potential of next-generation high-throughput technologies, including genomics, transcriptomics and

proteomics, to study the interactions of yeasts that cause disease to humans (e.g. Candida and Cryptococcus sp.)

with their host, and to develop new diagnostic tools to monitor yeast infections in the clinic.

 
Role of Ghent University
The Laboratory for Bacteriology Research (Faculty of Medicine & Health Sciences) will focus on Candida vaginitis (acute and chronic infection) and apply dual RNA sequencing to determine the expression of virulence characteristics in Candida albicans at the same time as the local vaginal immune respons of the patient. One ESR will carry out this research in close collaboration with the CRG (Barcelona, Spain) and the Hans Knoll Institute (Jena, Germany).
 
 
Disclaimer
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Research Executive Agency (REA). Neither the European Union nor the authority can be held responsible for them.